(Reuters) – Drugmaker Sanofi is working with Rothschild & Co on a separate listing of the consumer health division, which could be valued at more than $20 billion in any deal, Bloomberg News reported on Wednesday citing people familiar with the matter.
(Reporting by Urvi Dugar in Bengaluru; Editing by Chris Reese)
